Banning ephedra: good call, poor vision.
Gordon
James S
JS
Georgetown Medical School, Washington, DC, USA.
D016907:Adverse Drug Reaction Reporting Systems; D019440:Anti-Obesity Agents / Q000009:adverse effects*; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D019587:Dietary Supplements / Q000009:adverse effects*; D029789:Ephedra / Q000009:adverse effects*; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D008517:Phytotherapy; D010936:Plant Extracts / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration; D015431:Weight Loss / Q000187:drug effects
D019440:Anti-Obesity Agents; D000697:Central Nervous System Stimulants; D010936:Plant Extracts